 ALISO VIEJO, Calif., July 25, 2022 GLOBE NEWSWIRE -- NASDAQ: RXST RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that it will report financial results for the second quarter 2022 after the market close on Monday, August 8, 2022. The companys management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time 4:30 p.m. Eastern Time. 